Germany· DE-A57-73034ea7f2c8d495
Aureomycin
A chlortetracycline product containing chlortetracycline hydrochloride, registered in Germany by Abanta Pharma Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Chlortetracycline Hydrochloride
- Manufacturer
- Abanta Pharma Gmbh
- Country
- Germany (DE)
- ATC code
- J01AA03
- ATC class
- Chlortetracycline
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlortetracycline in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAureomycinWyeth Lederle Nordiska Ab
- CanadaAUREOMYCIN 220 GZOETIS CANADA INC
- SpainDERMOSA AUREOMICINA 10 MG/G POMADATeofarma S.R.L.
- FranceAUREOMYCINE EVANS 1 POUR CENT, pommade ophtalmiqueSCA PHARMA
- NorwayAureomycinUCB
- PolandChlorocyclinum 3%Chema-Elektromet Spółdzielnia Pracy
- United KingdomAureomycine Evans 1% eye ointmentImported (France)
- BelgiumAureomycin 1 %BePharBel Manufacturing
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Belgium · Aureomycin
- Spain · Dermosa Aureomicina, Oftalmolosa Cusí Aureomicina
- France · Aureomycine Evans
- Italy · Aureomicina
- Luxembourg · Aureomycin
- Poland · Chlorocyclinum 3 %
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/91c55fa9-f9e4-4ca0-b7de-e6b0c5b28e7f GET /v1/drugs/91c55fa9-f9e4-4ca0-b7de-e6b0c5b28e7f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Transdermal Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Chlortetracycline Hydrochloride",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about chlortetracycline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.